These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15181453)

  • 1. Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors.
    Sabah M; Cummins R; Leader M; Kay E
    Mod Pathol; 2004 Nov; 17(11):1364-71. PubMed ID: 15181453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.
    Zhang Y; Cao H; Wang M; Zhao WY; Shen ZY; Shen DP; Ni XZ; Wu ZY; Shen YY; Song YY
    World J Gastroenterol; 2010 Oct; 16(37):4716-24. PubMed ID: 20872974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of loss of heterozygosity at 9p21 and P16 expression in gastrointestinal stromal tumors].
    Zhang Y; Cao H; Wang M; Shen DP; Ni XZ; Wu ZY; Shen YY; Song YY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Oct; 13(10):762-5. PubMed ID: 20972908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
    Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
    Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p16INK4A expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected synovial sarcomas.
    Sabah M; Cummins R; Leader M; Kay E
    Virchows Arch; 2005 Nov; 447(5):842-8. PubMed ID: 16082560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16 (INK4A) expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors.
    Sabah M; Cummins R; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):97-102. PubMed ID: 16540739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M; Cummins R; Leader M; Kay E
    Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors.
    Kim NG; Kim JJ; Ahn JY; Seong CM; Noh SH; Kim CB; Min JS; Kim H
    Int J Cancer; 2000 Mar; 85(5):633-8. PubMed ID: 10699941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.
    Lourenço N; Hélias-Rodzewicz Z; Bachet JB; Brahimi-Adouane S; Jardin F; Tran van Nhieu J; Peschaud F; Martin E; Beauchet A; Chibon F; Emile JF
    Mol Cancer; 2014 Nov; 13():246. PubMed ID: 25373456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
    Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
    Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis.
    Liang CW; Yang CY; Flavin R; Fletcher JA; Lu TP; Lai IR; Li YI; Chang YL; Lee JC
    Hum Pathol; 2021 Jan; 107():69-79. PubMed ID: 33186588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 overexpression in BRAF-mutated gastrointestinal stromal tumors.
    Shi SS; Wang X; Xia QY; Rao Q; Shen Q; Ye SB; Li R; Shi QL; Lu ZF; Ma HH; Zhou XJ
    Expert Rev Mol Diagn; 2017 Feb; 17(2):195-201. PubMed ID: 28034324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.
    Jares P; Fernández PL; Nadal A; Cazorla M; Hernández L; Pinyol M; Hernández S; Traserra J; Cardesa A; Campo E
    Oncogene; 1997 Sep; 15(12):1445-53. PubMed ID: 9333020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.